A clinical trial to study the effects of 2 doses of Magnesium sulphate in patients undergoing awake fiberoptic laryngoscopy
Not Applicable
Completed
- Conditions
- Health Condition 1: S024- Fracture of malar, maxillary and zygoma bonesHealth Condition 2: S026- Fracture of mandible
- Registration Number
- CTRI/2019/02/017716
- Lead Sponsor
- IMS BH
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 80
Inclusion Criteria
ASA Grade I and II
Exclusion Criteria
ASA Grade III and IV
Allergy/Hypersensitivity to magnesium sulphate
Cardiac arrhythmia/CHD/Cardiopulmonary disease
Presence of cervical spine
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change in Ramsay Sedation ScoreTimepoint: During awake fiberoptic laryngoscopy
- Secondary Outcome Measures
Name Time Method Changes in blood pressure and heart rateTimepoint: During awake fiberoptic laryngoscopy